Stay updated on MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial page.

Latest updates to the MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNo substantive changes to study data or history; only minor visual/layout differences between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference11%

- Check45 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page updated from Revision: v3.0.1 to v3.0.2, indicating a minor version release. The 'Back to Top' element was removed, while core content, pricing, stock availability, and time-slot information appear unchanged.SummaryDifference0.7%

- Check67 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.7%

- Check74 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries.SummaryDifference22%

Stay in the know with updates to MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial page.